J&J beats third-quarter earnings expectations on higher prescription drug sales
October 15, 2019 at 06:47 AM EDT
J&J's pharmaceutical business, which accounts for half of the company's revenue, posted revenue of $10.88 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|